M2R
0.003
50%
CNJ
0.02
-73.7%
RAD
0.026
44.4%
NAE
0.002
-33.3%
MEM
0.004
33.3%
SPX
0.002
-33.3%
VKA
0.009
28.6%
RKB
0.003
-25%
RDN
0.005
25%
TAR
0.018
-25%
DRO
2.83
23%
OEL
0.004
-20%
NFM
0.017
21.4%
TDO
0.14
-17.6%
4DX
2.95
20.9%
BMO
0.033
-15.4%
VAR
0.006
20%
AX8
0.006
-14.3%
PTX
0.11
18.3%
BNL
0.006
-14.3%
BLU
0.007
16.7%
ECS
0.006
-14.3%
GLL
0.007
16.7%
ENV
0.006
-14.3%
MGL
0.245
16.7%
SER
0.006
-14.3%
VSR
0.035
16.7%
AZY
0.537
-13.4%
EOS
7.44
15.2%
ALM
0.007
-12.5%
BKB
0.8
15.1%
MML
0.028
-12.5%
SNX
0.031
14.8%
PL9
0.007
-12.5%
HPG
1.385
14.5%
SRJ
0.014
-12.5%
CLX
2.15
13.2%
GG1
0.185
-11.9%
MQR
0.009
12.5%
D3E
0.305
-11.6%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

LTR Pharma (ASX:LTP) rallies after second medical practitioner starts prescribing SPONTAN®

LTR Pharma (ASX:LTP) rallied on news that a second medical practitioner has been authorised to prescribe SPONTAN® under the Therapeutic Goods Administration (“TGA”) Special Access Scheme (“SAS”).. A second men’s health expert and clinical key opinion leader in Australia is now authorised to prescribe SPONTAN® – a novel treatment for erectile dysfunction (“ED”) LTR Pharma […]

August 8, 2024: TSN’s ASX weekly wrap

TSN ASX weekly wrap | The ASX 200 closed on Friday evening down 2.11%. The mood in the sector took a sharp downturn after overnight data indicated a weakening US economy, reigniting concerns that persistently high interest rates could lead to a recession #ASX #ASXStocks #investment #australianstockhorse #stockshow #investing #asxweeklywrap

Nuren Group Limited (NSX:NRN): Lists on NSX

Nuren Group Limited (NSX:NRN) has listed on the National Stock Exchange of Australia with a ticker code of NRN, achieving an initial market value of $30.9 million. Nuren Group is the holding company of Enlinea who operates an e-commerce platform in Malaysia called motherhood.com.my. The platform generates revenue by purchasing products from suppliers at a […]

Gold Mountain (ASX:GMN): Achieves further exploration success

Gold Mountain (ASX:GMN) has received a batch of 54 stream sediment samples from the Irajuba tenements in the Down Under Project area in Brazil 🪨 Very high grade results in stream sediment samples demonstrate 👉 Jiquiriçá tenements in Down Under have excellent REE potential. ASX announcement: https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02836200-2A1539635&v=fc9bdb61fe50ea61f8225e24ce041a0e155a9400

What’s Hot – BPH, HCL, CTM, LBT, HCH, AW1, AWJ & PSC

What’s Hot, Not & Doing Brought to you by TSN Contributor & Wealth Advisor Nick Kelso What’s Hot – BPH, HCL, CTM, LBT, HCH, AW1, AWJ & PSC What’s Not – CAZ & MOZ What’s Hot BPH – BPH Energy Limited today closed up 38% to finish at 2.2c on $1.3m stock traded. The reason […]

Nyrada Inc. (ASX:NYR): Developing NYR-BI03

Nyrada Inc. (ASX:NYR) has made progress on developing NYR-BI03, a first in class neuroprotection treatment for both traumatic brain injury (TBI) and stroke. – Additional study provided further data to support safety and tolerability of Nyrada’s lead Brain Injury drug candidate. – Rat CNS testing satisfactorily completed under Good Laboratory Practice (GLP) conditions for NYR-BI03. […]

LTR Pharma (ASX:LTP) indicates first patients have received SPONTAN® under TGA Scheme

LTR Pharma (ASX:LTP) has announced that the first patients have received SPONTAN®, a nasal spray treatment for erectile dysfunction (ED), under the Therapeutic Goods Administration (TGA) Special Access Scheme.  First patients receive SPONTAN® under the TGA Special Access Scheme Demonstrates potential for SPONTAN® in an unmet fast-acting, on-demand erectile dysfunction treatment market Internationally recognised Key […]

Short Video: Tryptamine Therapeutics (ASX:TYP): Clinical-stage biotech focused on psychedelic drug development

Tryptamine Therapeutics Limited (ASX:TYP) is a clinical-stage biotech and its current primary focus is the development of an innovative and scalable intravenous-infused psilocin formulation which can be used in conjunction with psychotherapy to address significant unmet medical needs. Tryptamine Therapeutics CEO and Executive Director Jason Carroll speaks with The Stock Network’s Lel Smits. 🧬 Phase […]

AML3D (ASX:AL3): Announces Arcemy® ‘X-Edition’ Commissioned at US Navy supplier cogitic corp

AML3D (ASX:AL3) announces Arcemy® ‘X-Edition’ Commissioned at US Navy supplier cogitic corp ➡️ The A$2.5 million ARCEMY® ‘X-Edition 6700’ ordered by US Defence contractor, Cogitic Corporation, is now commissioned and operational. ➡️ Cogitic is positioned to supply ARCEMY® metal 3D printed’, ‘cannot fail’, components to the US Navy and other defence applications. ASX Announcement: https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02835365-6A1219268&v=70bc033a22188bdfefb8a0b8ad3c24897ef2837d

Western Gold Resources (ASX: WGR): Completes a mining-level Aboriginal heritage survey

Western Gold Resources (ASX: WGR) has completed a mining-level Aboriginal heritage survey at the Company’s 100% owned Gold Duke Project in the north-eastern goldfields of Western Australia. – Aboriginal heritage clearance secured – Additional surveys planned for Q3 to expand gold production – Scoping study underway to determine best processing method for 4.57Mt gold resource […]